Camurus AB (Sweden) Insiders
CAMX Stock | SEK 709.00 20.50 2.81% |
Camurus AB employs about 170 people. The company is managed by 20 executives with a total tenure of roughly 154 years, averaging almost 7.0 years of service per executive, having 8.5 employees per reported executive. Breaking down Camurus AB's management performance can provide insight into the firm performance.
Fredrik Tiberg CEO President, Chief Executive Officer, Director |
Per Wallstrom Chairman Independent Chairman of the Board |
Camurus |
Camurus AB Management Team Effectiveness
The company has return on total asset (ROA) of 0.0146 % which means that it generated a profit of $0.0146 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0317 %, meaning that it generated $0.0317 on every $100 dollars invested by stockholders. Camurus AB's management efficiency ratios could be used to measure how well Camurus AB manages its routine affairs as well as how well it operates its assets and liabilities.Camurus AB Workforce Comparison
Camurus AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,139. Camurus AB holds roughly 170 in number of employees claiming about 8% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03. Camurus AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Camurus AB Price Series Summation is a cross summation of Camurus AB price series and its benchmark/peer.
Camurus AB Notable Stakeholders
A Camurus AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Camurus AB often face trade-offs trying to please all of them. Camurus AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Camurus AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Fredrik Tiberg | President, Chief Executive Officer, Director | Profile | |
Per Wallstrom | Independent Chairman of the Board | Profile | |
Fredrik Joabsson | Vice President Business Development and Alliance Management | Profile | |
Agneta Svedberg | Vice President, Clinical Development & Pharmacovigilance | Profile | |
Torsten Malmstrom | Vice President Technical Operations | Profile | |
Urban Paulsson | Vice President Corporate Development & General Counsel | Profile | |
Eva PinottiLindqvist | Chief Financial Officer | Profile | |
Mark Never | Independent Director | Profile | |
PerAnders Abrahamsson | Independent Director | Profile | |
Kerstin Strinnholm | Independent Director | Profile | |
Behshad Sheldon | Independent Director | Profile | |
Marianne Alexandersson | Independent Director | Profile | |
Martin Jonsson | Independent Director | Profile | |
Annette Mattsson | Vice President - Regulatory Affairs | Profile | |
Rein BSc | VP Relations | Profile | |
Richard Jameson | Chief Commercial Officer | Profile | |
Maria Lundqvist | Global HR | Profile | |
Peter Hjelmstrom | Chief Officer | Profile | |
Andrew McLean | VP Counsel | Profile | |
Jon Alonso | Chief Officer | Profile |
About Camurus AB Management Performance
The success or failure of an entity such as Camurus AB often depends on how effective the management is. Camurus AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Camurus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Camurus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Camurus AB , a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company was founded in 1991 and is headquartered in Lund, Sweden. Camurus AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 140 people.
Please note, the imprecision that can be found in Camurus AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Camurus AB. Check Camurus AB's Beneish M Score to see the likelihood of Camurus AB's management manipulating its earnings.
Camurus AB Workforce Analysis
Traditionally, organizations such as Camurus AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Camurus AB within its industry.Camurus AB Manpower Efficiency
Return on Camurus AB Manpower
Revenue Per Employee | 3.5M | |
Revenue Per Executive | 30M | |
Net Loss Per Employee | 650.4K | |
Net Loss Per Executive | 5.5M | |
Working Capital Per Employee | 3.4M | |
Working Capital Per Executive | 28.7M |
Additional Tools for Camurus Stock Analysis
When running Camurus AB's price analysis, check to measure Camurus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Camurus AB is operating at the current time. Most of Camurus AB's value examination focuses on studying past and present price action to predict the probability of Camurus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Camurus AB's price. Additionally, you may evaluate how the addition of Camurus AB to your portfolios can decrease your overall portfolio volatility.